Herpes zoster, commonly known as shingles, is caused by the reactivation of the varicella-zoster virus, the same virus that causes chickenpox. It typically presents as a painful skin rash and may lead to severe complications, especially in older adults. GlaxoSmithKline's Shingrix, approved in 2017, is considered effective in preventing shingles and its associated complications.
The company we are profiling today is Dynavax Technologies Corp. (DVAX), which is also developing a shingles vaccine.
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.